Prof. Clive Page is Professor of Pharmacology and Director of the Sackler Institute of Pulmonary Pharmacology, King’s College London. Clive’s main research interests are in the pharmacology of inflammation and respiratory disease and he has published over 250 scientific papers. Clive is the co-founder and acted as Chairman of the Board of Verona Pharma (NASDAQ: VRNA) developing new drugs for the treatment of respiratory diseases. He was also a Non-Executive Director of Helperby Therapeutics, a spin out Company from St. George’s Hospital Medical School developing novel anti-infective drugs. He is Non Executive Director of PreP Biopharma, EpiEndo, Babraham Biotechnology Ltd., as well as a Trustee of the Babraham Institute in Cambridge.
Clive started his early career in the pharmaceutical industry at Sandoz Ltd, Basel, Switzerland and regularly consults to both the pharmaceutical and biotech Industry. Clive was also the previous Chairman of the Board of Peptinnovate a former Chairman of the Animal Science Group of the Society of Biology and a Council Member of Understanding Animal Research. He was awarded the Society of Biology President’s Medal in 2012 for an outstanding contribution to the life sciences. He is a Fellow of the Royal Society of Biology and an Honorary Fellow and President Elect of the British Pharmacological Society. In 2017, Clive was awarded an OBE for Services to Pharmacology.